Scentech Medical Technologies Ltd
7
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study
Role: lead
Detection of COVID-19 Using Breath Analysis - Validation Study.
Role: lead
Detection of COVID-19 Using Breath Analysis - Validation Study
Role: lead
Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
Role: lead
Early Detection of COVID-19 Using Breath Analysis - Feasibility Study
Role: lead
Early Detection of COVID-19 Using Breath Analysis
Role: lead
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
Role: lead
All 7 trials loaded